SCHEMBL476637

SCHEMBL476637

Cc1ccc2cc(C)n(CCCNS(C)(=O)=O)c2c1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
POLB P06746 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
FGB P02675 1/20 0.36
TLR7 Q9NYK1 1/20 0.35
USP2 O75604 1/20 0.34
ESR1 P03372 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CASP1 P29466 1/20 0.34
CYP2C19 P33261 1/20 0.34
CNR2 P34972 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
PLK1 P53350 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476681 0.82 MEN1 (0.39) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476619 0.80 ALDH1A1 (0.39) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476538 0.78 SMN1; SMN2 (0.40) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476604 0.78 RECQL (0.41) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476636 0.76 HTR7 (0.39) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476641 0.74 MEN1 (0.61) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476594 0.73 ALDH1A1 (0.37) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476630 0.69 TRPV4 (0.34) ALDH1A1TLR7CNR2TDP1PLK1
SCHEMBL476675 0.68 LMNA (0.34) ALDH1A1POLBKMT2AMEN1MAPT
SCHEMBL476677 0.65 SMN1; SMN2 (0.40) POLBKMT2AMEN1MAPTFGB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951225-B1 3-ACYLINDOLE DERIVATIVES THE PREPARATION AND THE THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-02-01 EP disclosed
US-7741363-B2 3-Acylindole derivatives, preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2010-06-22 US disclosed
US-20080275102-A1 3-ACYLINDOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275102-A1 3-ACYLINDOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF F12, ECI1, NQO2 ALDH1A1 182/4885POLB 4291/4885KMT2A 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.